Do nature of bacteremia and origin of secondary sepsis in critically ill patients determine subset of myeloid-derived suppressor cells expansion?

Ivo Udovičić; Maja  Šurbatović; Goran  Rondović; Ivan Stanojević; Snježana  Zeba; Dragan  Djordjević; Aneta  Perić; Snežana  Milosavljević; Nikola  Stanković; Dzihan  Abazović; Danilo  Vojvodić

doi:10.2298/VSP181008174U

Ivo Udovičić Military Medical Academy , Clinic of Anesthesiology and Intensive Therapy Belgrade, Serbia
Maja Šurbatović Military Medical Academy, Clinic of Anesthesiology and Intensive Therapy, Belgrade, Serbia
Goran Rondović Military Medical Academy, Clinic of Anesthesiology and Intensive Therapy, Belgrade, Serbia
Ivan Stanojević University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Snježana Zeba Military Medical Academy, Clinic of Anesthesiology and Intensive Therapy, Belgrade, Serbia
Dragan Djordjević Military Medical Academy, Clinic of Anesthesiology and Intensive Therapy, Belgrade, Serbia
Aneta Perić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Snežana Milosavljević Clinical Hospital Center Kosovska Mitrovica, Department of Anesthesiology, Kosovska Mitrovica, Serbia
Nikola Stanković Mother and Child Health Care Institute of Serbia, Department of Anesthesiology and Intensive Therapy, Belgrade, Serbia
Dzihan Abazović Emergency Medical Centar of Montenegro, Podgorica, Montenegro
Danilo Vojvodić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP181008174U

Keywords: gram-negative bacteria, gram-positive bacteria, critical illness, myeloid-derived suppressor cells, sepsis

Abstract

Background/Aim. Gram-positive and Gram-negative bacteria may induce different inflammatory patterns. The aim of this study was to examine the association of the myeloid-derived suppressor cells (MDSCs) with the type of infecting microorganisms (Gram positive, Gram negative, polymicrobial) and underlying cause of secondary sepsis (peritonitis, pancreatitis, trauma). Methods. Totally, 40 critically ill patients with secondary sepsis were enrolled in the prospective study. Two patients without documented positive blood culture were excluded. We detected and enumerated both main subsets of MDSCs: granulocytic (G)-MDSCs and monocytic (M)-MDSCs on the Days 1 and 5. Blood was simultaneously drawn for a blood culture. The patients with different underlying causes of sepsis (peritonitis, pancreatitis, trauma) were perceived as separated groups and the frequencies and absolute numbers of their G-MDSCs and M-MDSCs were compared. Results. Both main MDSC subpopulations were accumulated significantly in Gram-positive sepsis. Univariate logistic regression analyses of investigated variables regarding Gram-positive sepsis on the Day 5 revealed that G-MDSCs absolute number along with both M-MDSCs frequency and absolute number had statistically significant power for predicting Gram-positive sepsis. Stepwise multivariate logistic regression analyses of the variables on the Day 5 determined that M-MDSCs absolute number was independent predictor of Gram-positive sepsis [odds ratio (OR) 1.012; p < 0.05]. Clinical accuracy of neutrophil (Ne)/G-MDSCs (Ne/G-MDSCs) and monocyte (Mo)/M-MDSCs (Mo/M-MDSCs) ratios in predicting nature of bacteremia and outcome were investigated. Discriminative power of both Ne/G-MDSCs and Mo/M-MDSCs ratios in predicting Gram-positive blood culture was statistically significant both on the Day 1 and Day 5 [areas under curve (AUCs): 0.684 and 0.692, and 0.707 and 0.793, respectively). Ne/G-MDSCs both on the Day 1 and Day 5 were statistically significant predictors of lethal outcome (AUCs: 0.694 and 0.678, respectively). There were no statistically significant differences in G-MDSCs and M-MDSCs among different three groups of patients regarding peritonitis, pancreatitis and trauma as causes of sepsis neither on the Day 1 nor on the Day 5. Conclusion. Gram-positive infectious agents were powerful inducers of MDSCs generation in sepsis. Also, underlying causes of secondary sepsis might not seem to influence the MDSCs accumulation.

References

Surbatovic M, Popovic N, Vojvodic D, Milosevic I, Acimovic G, Stojcic M, et al. Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci Rep 2015; 5: 11355.

Carlet J, Cohen J, Calandra T, Opal SM, Masur H. Sepsis: time to reconsider the concept. Crit Care Med 2008; 36(3): 964‒6.

Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T, et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators In-flamm 2018; 2018: 3758068.

Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, Laface DM, et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med 2011; 17(3‒4): 281‒92.

Udovicic I, Surbatovic M, Rondovic G, Stanojevic I, Zeba S, Djordjevic D, et al. Myeloid-derived suppressor cells in sec-ondary sepsis: is there association with lethal outcome? Vojno-sanit Pregl 2018; DOI: https://doi.org/10.2298/VSP180706133U.

Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999; 25(7): 686‒96.

Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270(24): 2957‒63.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13(10): 818‒29.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Fer-rer R, et al. Surviving Sepsis Campaign: International Guide-lines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017; 45(3): 486‒552.

Surbatovic M, Veljovic M, Jevdjic J, Popovic N, Djordjevic D, Rada-kovic S. Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma. Mediators Inflamm 2013; 2013: 362793.

Surbatovic M, Vojvodic D, Khan W. Immune Response in Criti-cally Ill Patients. Mediators Inflamm 2018; 2018: 9524315.

Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9(3): 162‒74.

Ribechini E, Greifenberg V, Sandwick S, Lutz MB. Subsets, ex-pansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol 2010; 199(3): 273‒81.

Ost M, Singh A, Peschel A, Mehling R, Rieber N, Hartl D. Mye-loid-Derived Suppressor Cells in Bacterial Infections. Front Cell Infect Microbiol 2016; 6: 37.

Minejima E, Bensman J, She RC, Mack WJ, Tuan Tran M, Ny P, et al. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia. Crit Care Med 2016; 44(4): 671‒9.

Janols H, Bergenfelz C, Allaoui R, Larsson AM, Rydén L, Björns-son S, et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol 2014; 96(5): 685‒93.

Hotchkiss RS, Moldawer LL. Parallels between cancer and in-fectious disease. N Engl J Med 2014; 371(4): 380‒3.

Gabrilovich DI. Editorial: The intricacy of choice: can bacteria decide what type of myeloid cells to stimulate? J Leukoc Biol 2014; 96(5): 671‒4.

Uhel F, Azzaoui I, Grégoire M, Pangault C, Dulong J, Tadié JM, et al. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomi-al Infections in Patients with Sepsis. Am J Respir Crit Care Med 2017; 196(3): 315‒27.

Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mecha-nisms, molecules and clinical significance. Trends Immunol 2009; 30(10): 475‒87.

Bergenfelz C, Larsson AM, von Stedingk K, Gruvberger-Saal S, Aaltonen K, Jansson S, et al. Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Pro-gression in Breast Cancer Patients. PLoS One 2015; 10(5): e0127028.

Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE. Endotoxin tolerance represents a distinctive state of alternative polariza-tion (M2) in human mononuclear cells. J Immunol 2011; 186(12): 7243‒54.

Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kap-paB. Proc Natl Acad Sci U S A 2009; 106(35): 14978‒83.

Xu PB, Lou JS, Ren Y, Miao CH, Deng XM. Gene expression profiling reveals the defining features of monocytes from sep-tic patients with compensatory anti-inflammatory response syndrome. J Infect 2012; 65(5): 380‒91.

Mages J, Dietrich H, Lang R. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 2007; 212(9‒10): 723‒37.

Zhao L, Shao Q, Zhang Y, Zhang L, He Y, Wang L, et al. Hu-man monocytes undergo functional re-programming during differentiation to dendritic cell mediated by human extravil-lous trophoblasts. Sci Rep 2016; 6: 20409.

Shalova IN, Lim JY, Chittezhath M, Zinkernagel AS, Beasley F, Hernández-Jiménez E, et al. Human monocytes undergo func-tional re-programming during sepsis mediated by hypoxia-inducible factor-1α. Immunity 2015; 42(3): 484‒98.